Vitruvias Therapeutics

About:

Vitruvias Therapeutics focuses on developing niche topical generic products that are sold only by prescription.

Top Investors: Perceptive Advisors, JW Asset Management

Description:

Vitruvias Therapeutics is a start-up generic pharmaceutical company that will focus on developing niche topical generic products that are sold only by prescription. The name of the company is taken from Leonardo da Vinci’s drawing “The Vitruvian Man” which refers to the idealized proportionality of the human figure. The company was founded in 2013 and is based in Montgomery, Alabama.

Total Funding Amount:

$12.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montgomery, Alabama, United States

Founded Date:

2013-01-01

Contact Email:

carl(AT)vitruvias.com

Founders:

Bryce Harvey, Carl Whatley

Number of Employees:

1-10

Last Funding Date:

2018-01-05

IPO Status:

Private

Industries: